[Typical and atypical features of focal nodular hyperplasia of the liver on helical CT images].

Ai Zheng

State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.

Published: July 2006

Background & Objective: Focal nodular hyperplasia (FNH) is a rare hepatic neoplastic lesion. This study was to evaluate the typical and atypical features of FNH of the liver on helical computed tomography (CT) images to improve the diagnosis accuracy.

Methods: Helical CT images of 32 patients with 37 lesions were reviewed in Cancer Center, Sun Yat-sen University retrospectively, who were confirmed as FNH by histopathologic or clinic examinations. The number, size, margin status, density, enhancing type, presence of a center scar, and presence of a pseudocapsule of FNH lesions were analyzed.

Results: The largest diameters of 14 lesions were < or = 3 cm, of 23 lesions were > 3 cm; 20 lesions were subcapsular; pseudocapsule was presented in 7 lesions with the largest diameters of > 3 cm; 22 lesions had center scars, among them, the largest diameters of 20 lesions was > 3 cm. All lesions were hyperattenuated to the liver in hepatic arterial phase; 31 lesions were enhanced homogeneously in hepatic arterial phase; abnormally thickened vessels were presented at the border of 17 lesions.

Conclusions: Typical helical CT features of FNH include homogeneous enhancement in hepatic arterial phase, presence of central scar, and delayed enhancement. Atypical helical CT features of FNH include heterogeneous enhancement in hepatic arterial phase, absence of central scar, and presence of pseudocapsule. The various CT features are related to the pathologic type and the largest diameter of the lesion.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hepatic arterial
16
arterial phase
16
features fnh
12
largest diameters
12
diameters lesions
12
lesions lesions
12
lesions
10
atypical features
8
focal nodular
8
nodular hyperplasia
8

Similar Publications

Integrated Management of Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Expanding Roles of SGLT2is, GLP-1RAs, and GIP/GLP-1RAs.

Biomedicines

January 2025

Department of Cardiology & Preventive Cardiology Outpatient Clinic, Amalia Fleming General Hospital, 14, 25th Martiou Str., 15127 Melissia, Greece.

Cardiovascular-Kidney-Metabolic syndrome, introduced by the American Heart Association in 2023, represents a complex and interconnected spectrum of diseases driven by shared pathophysiological mechanisms. However, this framework notably excludes the liver-an organ fundamental to metabolic regulation. Building on this concept, Cardiovascular-Renal-Hepatic-Metabolic (CRHM) syndrome incorporates the liver's pivotal role in this interconnected disease spectrum, particularly through its involvement via metabolic dysfunction-associated steatotic liver disease (MASLD).

View Article and Find Full Text PDF

Objective: CT liver perfusion (CTLP) has been well validated for hepatocellular carcinoma (HCC) detection, characterization, and treatment response evaluation. However, its role in HCC management algorithms remains unclear. This study aims to assess the diagnostic performance of CTLP alone or as an adjunct to MRI in patients considered for- or undergoing locoregional treatment for HCC.

View Article and Find Full Text PDF

Objectives: This retrospective study aimed to investigate the feasibility of surgical closure of ventricular septal defect in children with trisomy 18 by assessing perioperative events and long-term survival.

Methods: From April 2008 to March 2024, 41 consecutive patients were referred to us for ventricular septal defect surgery. The defect was closed in 35 patients at the end (median age, 16 months; median body weight, 5.

View Article and Find Full Text PDF

Systemic arterial hypertension contributes to cardiovascular morbidity and mortality worldwide. Many patients cannot achieve optimal blood pressure (BP) control with traditional therapies, which often results in poor patient adherence and limited long-term efficacy. We investigated the potential of RNA interference (RNAi) therapies targeting hepatic angiotensinogen (AGT) for hypertension management.

View Article and Find Full Text PDF

Background: The aim of this study was to compare microwave ablation (MWA) with and without prior placement of an intra-arterial catheter for the purpose of application of contrast medium (CM).

Methods: 148 patients (45 female, 65.1 ± 14.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!